Cargando…

The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A

Background: Patients with chronic spontaneous urticaria (CSU), an autoimmune disorder, show increased skin expression of IL-17A and can benefit from treatment with the anti-IL-17A biologic secukinumab. The mechanisms that drive IL-17A expression in CSU are currently unknown, but may involve Semaphor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lobna, Matanis, Nasren, Eiza, Adi, Sabag, Jacob, Bejar, Maria, Gimenez-Arnau Ana, Marcus, Maurer, Zahava, Vadasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998863/ https://www.ncbi.nlm.nih.gov/pubmed/33801296 http://dx.doi.org/10.3390/biom11030373

Ejemplares similares

Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma
por: Adi, Sabag D., et al.
Publicado: (2019)

Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases
por: Eiza, Nasren, et al.
Publicado: (2023)

The Emerging Role of IL-17 in the Immune-Pathogenesis of Chronic Spontaneous Urticaria
por: Toubi, Elias, et al.
Publicado: (2020)

Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
por: Bejar, Jacob, et al.
Publicado: (2018)

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
por: Metz, Martin, et al.
Publicado: (2020)

The Expansion of CD25(high)IL-10(high)FoxP3(high) B Regulatory Cells Is in Association with SLE Disease Activity
por: Vadasz, Zahava, et al.
Publicado: (2015)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

Expression of Semaphorin 3A in Malignant and Normal Bladder Tissue: Immunohistochemistry Staining and Morphometric Evaluation
por: Bejar, Ilan, et al.
Publicado: (2021)

Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?
por: Willner, Nadav, et al.
Publicado: (2018)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
por: Casale, Thomas B., et al.
Publicado: (2023)

Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria
por: Bernstein, Jonathan A., et al.
Publicado: (2023)

Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria
por: Kolkhir, Pavel, et al.
Publicado: (2021)

Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria
por: Lin, Wei, et al.
Publicado: (2017)

Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
por: Giménez‐Arnau, Ana, et al.
Publicado: (2022)

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
por: Moñino‐Romero, Sherezade, et al.
Publicado: (2023)

Semaphorin-3D and Semaphorin-3E Inhibit the Development of Tumors from Glioblastoma Cells Implanted in the Cortex of the Brain
por: Sabag, Adi D., et al.
Publicado: (2012)

Definition of Recurrent Chronic Spontaneous Urticaria
por: MELÉ-NINOT, Gemma, et al.
Publicado: (2020)

Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from the validation of the Polish Urticaria Control Test()
por: Brzoza, Zenon, et al.
Publicado: (2022)

Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria()
por: Metz, Martin, et al.
Publicado: (2022)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus
por: Vadasz, Zahava, et al.
Publicado: (2012)

Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
por: Krause, Karoline, et al.
Publicado: (2023)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients
por: Hexner-Erlichman, Zufit, et al.
Publicado: (2022)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

Looking forward to new targeted treatments for chronic spontaneous urticaria
por: Kocatürk, Emek, et al.
Publicado: (2017)

On the Lipophilic Nature of Autoreactive IgE in Chronic Spontaneous Urticaria
por: Lakin, Elisa, et al.
Publicado: (2019)

IL-6 Transsignaling in Patients with Chronic Spontaneous Urticaria
por: Kasperska-Zajac, Alicja, et al.
Publicado: (2015)

Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria
por: Kocatürk, Emek, et al.
Publicado: (2017)

ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
por: Weller, Karsten, et al.
Publicado: (2015)

In Chronic Spontaneous Urticaria, Comorbid Depression Linked to Higher Disease Activity, and Substance P Levels
por: Memet, Bachar, et al.
Publicado: (2021)

Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results
por: Maurer, Marcus, et al.
Publicado: (2020)

In silico Identification of Immune Cell-Types and Pathways Involved in Chronic Spontaneous Urticaria
por: Prosty, Connor, et al.
Publicado: (2022)

Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease
por: Curto‐Barredo, Laia, et al.
Publicado: (2016)

Diagnosis of urticaria
por: Schoepke, Nicole, et al.
Publicado: (2013)

Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
por: Durda, J., et al.
Publicado: (2017)

Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria
por: Kocatürk, Emek, et al.
Publicado: (2019)

Management of chronic spontaneous urticaria: a worldwide perspective
por: Kolkhir, Pavel, et al.
Publicado: (2018)

Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)
por: Jauregui, Ignacio, et al.
Publicado: (2019)

Contact Urticaria Syndrome: a Comprehensive Review
por: Giménez-Arnau, Ana M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e8gf7q80cmih0n4rjfcahka16u